F5 and cancer: FVL mutation interacts with other concurrent acquired and thrombophilic conditions such as cancer, oral contraceptive use, hormonal replacement therapy, pregnancy, surgery, long-haul air travel, and associated prothrombotic genetic abnormalities and essentially prothrombin G 20210A mutation to increase the risk of incident venous thrombosis [35].